Abstract:<p>In mammalian cells, N-glycans may include multiple N-acetyllactosamine (poly-LacNAc) units that can play roles in various cellular functions and properties of therapeutic recombinant proteins. Previous studies indicated that β-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2) and β-1,4-galactotransferase 1 (B4GALT1) are two of the primary glycosyltransferases involved in generating LacNAc units. In the current study, knocking out sialyltransferase genes slightly enhanced the LacNAc content (≥4 repeats per glycan) on recombinant EPO protein. Next, the role of single and dual-overexpression of B3GNT2 and B4GALT1 was explored in recombinant EPO-expressing Chinese hamster ovary (CHO) cells. While overexpression of B4GALT1 slightly enhanced the levels of large glycans on recombinant EPO, overexpression of B3GNT2 in EPO-expressing CHO cells significantly decreased the recombinant EPO LacNAc content, resulting in N-glycans terminating primarily with GlcNAc structures, a limited number of Gals, and nearly undetectable sialylation, which was also observed in sialyltransferases knock-out-B3GNT2 overexpression cell lines. Considering the nature of the binding domain motifs present on B3GNT2, which evolved from β1,3-galactosyltransferases, its overexpression may have competed and inhibited endogenous β1,4-galactosyltransferases for exposed GlcNAc residues on the N-glycans, resulting in premature termination of many N-glycans at GlcNAc. Furthermore, B3GNT2 overexpression enhanced intracellular UDP-GlcNAc and CMP-Neu5Ac content while slightly lowering UDP-Gal content. The presence of a sink for UDP-GlcNAc in the form of B3GNT2 with no disposition may have also elevated the intracellular levels of this nucleotide as well as its downstream product, CMP-Neu5Ac. Furthermore, we were unable to overexpress B4GALT1 at either the transcriptional or translational levels following initial B3GNT2 expression. Expression of B3GNT2 following initial expression of B4GALT1 was also problematic in that transcriptional and translational analysis indicated the accumulation of truncated B3GNT2 missing a section of the B3GNT2 trans-Golgi lumen domain while transmembrane and cytoplasmic domains were present. Given that glycosylation is a very complex intra-network process, the addition of one or more recombinant glycosyltransferases may have an unexpected influence on the expression and activities of glycosyltransferases, which can disrupt the nucleotide sugar levels and lead to unexpected modifications of the resulting N-glycan patterns.</p>

A widely compatible expression system for the production of highly O-GlcNAcylated recombinant protein in Escherichia coli

A Highly Effective and Adjustable Dual Plasmid System for O-Glcnacylated Recombinant Protein Production in E-Coli

Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells.

Overexpression and topology of bacterial oligosaccharyltransferase PglB.

OGT Binding Peptide-Tagged Strategy Increases Protein O-GlcNAcylation Level in E. Coli

A simple bacterial expression system for human ppGalNAc-T and used for the synthesis of O-GalNAc glycosylated interleukin 2

Construction of an Escherichia coli chassis for efficient biosynthesis of human-like N-linked glycoproteins

Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris

Optimizing Expression and Purification of an ATP-binding Gene Gsia from Escherichia Coli K-12 by Using GFP Fusion

Expression, purification, and characterization of a new Glucosyltransferase involved in the third step of O-antigen repeating-unit biosynthesis of Escherichia coli O152

Engineering Extracellular Expression Systems in Escherichia coli Based on Transcriptome Analysis and Cell Growth State.

Multilevel Systematic Optimization To Achieve Efficient Integrated Expression of Escherichia coli

Increased glycosylation efficiency of recombinant proteins in Escherichia coli by auto-induction

Highly Efficient Enrichment of O-GlcNAc Glycopeptides Based on Chemical Oxidation and Reversible Hydrazide Chemistry

Metabolic engineering challenges of extending N-glycan pathways in Chinese hamster ovary cells

Engineering an optimized expression operating unit for improved recombinant protein production in Escherichia coli

Enhancing glucaric acid production from myo-inositol in Escherichia coli by eliminating cell-to-cell variation

Engineering of N. benthamiana L. plants for production of N-acetylgalactosamine-glycosylated proteins - towards development of a plant-based platform for production of protein therapeutics with mucin type O-glycosylation

Combinatorial Metabolic Engineering of Escherichia Coli for De novo Production of Structurally Defined and Homogeneous Amino Oligosaccharides

Simplified Construction of Engineered Bacillus subtilis Host for Improved Expression of Proteins Harboring Noncanonical Amino Acids.

Srna-Based Screening Chromosomal Gene Targets and Modular Designing Escherichia Coli for High-Titer Production of Aglycosylated Immunoglobulin G.